Product Details: AC-262,356 Liquid
AC-262,356 is a man-made, non-steroidal compound called a selective androgen receptor modulator (SARM). Scientists use it in lab experiments and preclinical studies to study how androgen receptors (ARs) work in cells. It helps researchers see how these receptors control gene activity and other cell responses.
The liquid form of AC-262,356 is made with a research-grade solvent. This helps it dissolve well, stay stable, and be easy to measure for experiments.
Mechanism of Action
AC-262,356 works by binding to androgen receptors (ARs), which are special proteins in cells that help control gene activity. When AC-262,356 attaches to these receptors, it changes their shape. This lets the receptor move into the cell’s nucleus and interact with DNA at sites called androgen response elements (AREs).
This interaction controls which genes are turned on or off in the cell, affecting how cells send signals and respond. Lab studies show that AC-262 Sarm partially activates the receptor, so it produces a smaller effect than a full activator would.
In experimental models, receptor activation by AC-262,356 leads to:
- Altered gene expression profiles
- Modulation of protein synthesis pathways
- Activation of intracellular signaling cascades
The way AC-262,356 works differently in various tissues is because some tissues have more androgen receptors, different amounts of helper proteins, and unique cellular environments. Scientists are still studying exactly how specific and selective these effects are. [1]
Properties of AC-262,356 Liquid
- Molecular Formula: C₁₈H₁₈N₂O
- Molecular Weight: 278.35 g/mol
- CAS Number: Not widely standardized
- Synonyms: AC‑262356, selective receptor modulator compound
Research Applications/Benefits of AC-262,356 Liquid
Cellular Signaling Investigations
AC-262,356 is utilized in in vitro and preclinical models to study androgen receptor-mediated signaling pathways and their downstream molecular effects. [1, 2]
Selective Receptor Modulation Studies
Its partial agonist profile supports investigation into selective receptor activation, enabling differentiation between full and partial transcriptional responses in experimental systems. [1, 2]
Gene Expression Analysis
The compound is applied in research exploring transcriptional regulation, particularly changes in gene expression mediated by androgen receptor engagement. [1,]
Tissue-Specific Experimental Models
AC262 is used to evaluate tissue-selective signaling mechanisms, aiding in the understanding of receptor distribution and localized molecular responses. [1, 2]
Experimental Model Development
It supports the design of pathway-specific research models, particularly those investigating ligand-receptor interactions and nuclear receptor pharmacology. [2, 3]
Why Choose Behemoth Labz to Buy AC-262,356 Liquid
Choose Behemoth Labz, choose quality! We are among the few online sellers that believe in the integrity and purity of products. We offer AC262 for sale, which is designed to meet the industrial criteria and the needs of researchers.
Before launching our products, we test them through an independent laboratory to check their purity and ingredients. This procedure maximizes the accuracy and findings of your research experiments.
Additionally, we deliver nationwide and internationally. We use a secure payment system that safeguards your personal information and prevents unauthorized third-party access.
So, purchase AC-262,356 now and experience quality and purity for your research.
Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments.
References:
- Piu, F., Gardell, L. R., Son, T., Schlienger, N., Lund, B. W., Schiffer, H. H., Vanover, K. E., Davis, R. E., Olsson, R., & Bradley, S. R. (2007). Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator. Journal of Steroid Biochemistry and Molecular Biology, 109(1–2), 129–137.
- Dalton, J. T., Taylor, R. P., Mohler, M. L., & Steiner, M. S. (2013). Selective androgen receptor modulators: Preclinical and clinical development. Current Opinion in Supportive and Palliative Care, 7(4), 345–351. https://doi.org/10.1097/SPC.0000000000000010
- Gao, W., Reiser, P. J., Coss, C. C., Phelps, M. A., Kearbey, J. D., Miller, D. D., & Dalton, J. T. (2005). Selective androgen receptor modulators (SARMs): Preclinical characterization and tissue selectivity. Endocrinology, 146(11), 4887–4897. https://doi.org/10.1210/en.2005-024
